We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nuformix Plc | LSE:NFX | London | Ordinary Share | GB00BYW79Y38 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.185 | 0.17 | 0.20 | 137,686 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -859k | -0.0012 | -1.50 | 1.34M |
TIDMNFX
RNS Number : 3235C
Nuformix PLC
28 September 2018
28 Setember 2018
Nuformix plc
("Nuformix" or the "Company")
PDMR
The Company was notified on 28 September 2018 that Kirk Siderman-Wolter, Non-Executive Director of the Company, bought 35,364 Nuformix plc ordinary shares of 0.1p each ("Shares") at a purchase price of 2.6p per share.
Following this transaction he holds 35,364 shares, representing 0.00077% of the issued share capital of the Company.
1 Details of the person discharging managerial responsibilities. a) Name Kirk Siderman-Wolter --------------------------------------- ------------------------------------------ 2 Reason for the notification ----------------------------------------------------------------------------------- a) Position/status Non-Executive Director --------------------------------------- ------------------------------------------ b) Initial notification Initial notification /Amendment --------------------------------------- ------------------------------------------ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ----------------------------------------------------------------------------------- a) Name Nuformix plc --------------------------------------- ------------------------------------------ b) LEI 2138003XG3H3I2J3BJ24 --------------------------------------- ------------------------------------------ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ----------------------------------------------------------------------------------- a) Description of the Ordinary Shares of 0.1p each financial instrument, type of instrument Identification code GB00BYW79Y38 b) Nature of the transaction Acquisition of ordinary Shares --------------------------------------- ------------------------------------------ c) Price(s) and volume(s) ------------------ ------------------- Price(s) Volume(s) ------------------ ------------------- 2.6p 35,364 ------------------ ------------------- d) Aggregated information - Aggregated volume 35,364 - Price 2.6p e) Date of the transaction 16.08.18 --------------------------------------- ------------------------------------------ f) Place of the transaction Standard List, London Stock Exchange --------------------------------------- ------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHPGURUBUPRUBR
(END) Dow Jones Newswires
September 28, 2018 05:10 ET (09:10 GMT)
1 Year Nuformix Chart |
1 Month Nuformix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions